Retina/Vitreous News

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Charles C. Wykoff, MD, PhD, provides an overview of the Bionic Eye System for late-stage retinitis pigmentosa.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Richard Small, CEO of Neurotech Pharmaceuticals, gives an update on NT-501, the company’s encapsulated cell therapy for macular telangiectasia.

FORT LAUDERDALE, Fla. — Virtual education will provide more opportunities for collaboration and networking for retina specialists, according to a speaker here.

FORT LAUDERDALE, Fla. — Despite efforts to promote more diverse patient populations, racial minority patient groups are underrepresented in diabetic macular edema trials, according to a study.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Pravin U. Dugel, MD, of Ocular Therapeutix, overviews clinical results for Axpaxli, an axitinib implant for wet age-related macular degeneration.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Ash Attia, PhD, of Bionic Vision Technologies discusses a novel suprachoroidal retinal prosthesis for retinitis pigmentosa.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Jay S. Duker, MD, of EyePoint Pharmaceuticals discusses lead product Duravyu.

SEATTLE — Patients with age-related macular degeneration in a veteran population experienced an increase in inactive disease after treatment with faricimab, according to a poster presented here.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Daniela Ferrara, MD, PhD, FASRS, discusses AI-based machine learning models to predict the visual acuity treatment response of Vabysmo.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Allen C. Ho, MD, FASRS, discusses 12-month data on MCO-010 optogenetic therapy for patients with retinitis pigmentosa.